Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
6-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
advertisement
Classification List
1 General aspects
0
1.1
Epidemiology
6
1.2 Population genetics
0
1.3
Pathogenesis
4
1.4
Quality of life
6
1.5
Glaucomas as cause of blindness
1
1.6
Prevention and screening
3
2 Anatomical structures in glaucoma
0
2.1
Conjunctiva
3
2.2
Cornea
5
2.3
Sclera
2
2.4
Anterior chamber angle
2
2.5
Meshwork
1
2.5.1
Trabecular meshwork
8
2.5.2
Schlemms canal
2
2.5.3 Scleral outlet channels
0
2.6 Aqueous humor dynamics
0
2.6.1
Production
2
2.6.2
Outflow
4
2.6.2.1 Trabecular meshwork
0
2.6.2.2 Uveoscleral
0
2.6.3
Compostion
1
2.7 Episcleral veins and venous pressure
0
2.8 Iris
0
2.9 Ciliary body
0
2.10 Lens
0
2.11 Vitreous body
0
2.12
Choroid, peripapillary choroid, peripapillary atrophy
1
2.13
Retina and retinal nerve fibre layer
11
2.14
Optic disc
9
2.15
Optic nerve
4
2.16 Chiasma and retrochiasmal central nervous system
0
2.17 Stem cells
0
2.20 Other
0
3
Laboratory methods
10
3.1
Microscopy
1
3.2
Electron microscopy
5
3.3
Immunohistochemistry
9
3.4
Molecular genetics
1
3.4.1
Linkage studies
16
3.4.2
Gene studies
2
3.5
Molecular biology incl. SiRNA
5
3.6
Cellular biology
4
3.7 Biochemistry
0
3.8 Pharmacology
0
3.9
Pathophysiology
2
3.10 Immunobiology
0
3.11 Pharmacogenetics
0
3.12
Proteomics
1
3.13 In vivo imaging
0
3.13.1 Laser Scanning
0
3.13.1.1 Confocal Scanning Laser Ophthalmoscopy
0
3.13.1.2 Confocal Scanning Laser Polarimetry
0
3.13.2 Optical Coherence Tomography
0
3.13.2.1 Anterior Segment
0
3.13.2.2 Posterior Segment
0
3.13.3 RGC Imaging
0
3.13.4 Other
0
3.20 Other
0
4 Tissue culture of ocular cells
0
5
Experimental glaucoma; animal models
19
5.1 Rodent
0
5.2 Primates
0
5.3 Other
0
6 Clinical examination methods
0
6.1
Intraocular pressure measurement; factors affecting IOP
23
6.1.1 Devices, techniques
0
6.1.2 Fluctuation, circadian rhythms
0
6.1.3 Factors affecting IOP
0
6.2 Tonography, aqueous flow measurement (see also 2.6)
0
6.3 Biomicroscopy (slitlamp)
0
6.3.1 Anterior segment
0
6.3.2 Posterior segment
0
6.4 Gonioscopy
0
6.5 Ophthalmoscopy
0
6.6 Visual field examination and other visual function tests
0
6.6.1
Conventional manual
1
6.6.2
Automated
7
6.6.3
Special methods (e.g. color, contrast, SWAP etc.)
5
6.7
Electro-ophthalmodiagnosis
6
6.8 Photography
0
6.8.1 Anterior segment
0
6.8.2
Posterior segment
4
6.9 Computerized image analysis
0
6.9.1
Laser scanning
22
6.9.1.1 Confocal Scanning Laser Ophthalmoscopy
0
6.9.1.2 Confocal Scanning Laser Polarimetry
0
6.9.2
Optical coherence tomography
11
6.9.2.1 Anterior
0
6.9.2.2 Posterior
0
6.9.5
Other
1
6.10 Fluorescein (ICG) angiography
0
6.10.1 Anterior segment
0
6.10.2
Posterior segment
1
6.11
Bloodflow measurements
14
6.12
Ultrasonography and ultrasound biomicroscopy
4
6.13
Provocative tests
2
6.19
Telemedicine
2
6.20
Progression
6
6.30 Other
0
8 Refractive errors in relation to glaucoma
0
8.1 Myopia
0
8.2 Hypermetropia
0
8.3 Contact lenses
0
8.4
Refractive surgical procedures
1
8.5 Other
0
9 Clinical forms of glaucomas
0
9.1
Developmental glaucomas
2
9.1.1
Congenital glaucoma, Buphthalmos
4
9.1.2
Juvenile glaucoma
2
9.1.3
Syndromes of Axenfeld, Rieger, Peters, aniridia
2
9.1.4
Other
2
9.2 Primary open angle glaucomas
0
9.2.1
Ocular hypertension
1
9.2.2
Other risk factors for glaucoma
10
9.2.3
Open angle glaucoma with elevated IOP
1
9.2.4
Normal pressure glaucoma
4
9.3
Primary angle closure glaucomas
2
9.3.1
Acute primary angle closure glaucoma (pupillary block)
2
9.3.2
Chronic primary angle closure glaucoma (pupillary block)
1
9.3.3 Plateau iris syndrome
0
9.3.4 Primary angle closure suspect
0
9.3.5 Primary angle closure
0
9.3.10
Other
3
9.4 Glaucomas associated with other ocular and systemic disorders
0
9.4.1
Steroid-induced glaucoma
4
9.4.2 Glaucomas associated with disorders of the cornea, conjunctiva, sclera
0
9.4.2.1 Iridocorneal endothelial syndrome (ICE, incl. irisatrophy)
0
9.4.2.2 Posterior polymorphous dystrophy
0
9.4.2.3 Fuchs' endothelial dystrophy
0
9.4.2.5 Other
0
9.4.3 Glaucomas associated with disorders of the iris and ciliary body
0
9.4.3.1
Pigmentary glaucoma
1
9.4.3.5 Other
0
9.4.4 Glaucomas associated with disorders of the lens
0
9.4.4.1
Exfoliation syndrome
5
9.4.4.2 Glaucomas associated with cataracts
0
9.4.4.3 Glaucomas associated with lens dislocation
0
9.4.4.5 Other
0
9.4.5
Glaucomas associated with disorders of the retina, choroid and vitreous
2
9.4.5.1
Neovascular glaucoma
3
9.4.5.5 Other
0
9.4.6
Glaucomas associated with inflammation, uveitis
5
9.4.7
Glaucomas associated with ocular trauma
1
9.4.8 Glaucomas associated with intraocular tumors
0
9.4.9 Glaucomas associated with elevated episcleral venous pressure
0
9.4.10 Glaucomas associated with hemorrhage
0
9.4.11 Glaucomas following intraocular surgery
0
9.4.11.1 Ciliary block (malignant) glaucoma
0
9.4.11.2
Glaucomas in aphakia and pseudophakia
1
9.4.11.3 Epithelial, fibrous, and endothelial proliferation
0
9.4.11.4 Glaucomas associated with corneal surgery
0
9.4.11.5
Glaucomas associated with vitreoretinal surgery
1
9.4.15
Glaucoma in relation to systemic disease
3
9.4.20 Other
0
10
Differential diagnosis e.g. anterior and posterior ischemic optic neuropathy
7
11 Medical treatment
0
11.1
General management, indication
10
11.2
Cholinergic drugs
2
11.3 Adrenergic drugs
0
11.3.1 Epinephrine
0
11.3.2 Thymoxamine, dapiprazole
0
11.3.3
Apraclonidine, brimonidine
5
11.3.4
Betablocker
15
11.3.5 Other
0
11.4
Prostaglandins
35
11.5
Carbonic anhydrase inhibitors
4
11.5.1 Systemic
0
11.5.2
Topical
8
11.6
Osmotic treatment
1
11.7
Treatment of bloodflow
2
11.8
Neuroprotection
3
11.9
Gene therapy
3
11.13 Combination therapy
0
11.13.1 Betablocker and pilocarpine
0
11.13.2 Betablocker and carbon anhydrase inhibitor
0
11.13.3 Betablocker and brimonidine
0
11.13.4 Betablocker and prostaglandin
0
11.13.5 Other
0
11.14
Investigational drugs; pharmacological experiments
6
11.15
Other drugs in relation to glaucoma
1
11.16 Vehicles, delivery systems, pharmacokinetics, formulation
0
11.17 Cooperation with medical therapy e.g. persistency, compliance, adherence
0
11.20
Other
4
12 Surgical treatment
0
12.1
General management, indication
2
12.2 Laser iridotomy
0
12.3 Laser iridoplasty
0
12.4
Laser trabeculoplasty and other laser treatment of the angle
2
12.7 Surgical iridectomy
0
12.8
Filtering surgery
3
12.8.1
Without tube implant
3
12.8.2
With tube implant or other drainage devices
5
12.8.3
Non-perforating
10
12.8.4 Using laser
0
12.8.5 Other
0
12.8.10
Woundhealing antifibrosis
6
12.8.11
Complications, endophthalmitis
6
12.9
Trabeculotomy, goniotomy
3
12.10
Cyclodestruction
3
12.11 Cyclodialysis
0
12.12
Cataract extraction
1
12.12.1 Intracapsular
0
12.12.2 Extracapsular
0
12.12.3 Phacoemulsification
0
12.14
Combined cataract extraction and glaucoma surgery
2
12.14.1 Intracapsular
0
12.14.2 Extracapsular
0
12.14.3
Phacoemulsification
2
12.15 Capsulotomy
0
12.16 Vitrectomy
0
12.17
Anesthesia
4
12.20
Other
2
13 Therapeutic prognosis and outcome
0
13.1 Prognostic factors
0
13.2 Outcome
0
13.2.1 IOP
0
13.2.2 Visual field
0
13.2.2.1 Progression
0
13.2.2.2 Improvement
0
13.2.3 Other
0
14
Costing studies; pharmacoeconomics
2
15
Miscellaneous
3
Issue
6-3
Table of Contents
Editor's Selection
Change Issue
24-3 (2024)
24-1/2 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement